Skip to main content

Research Repository

Advanced Search

Is CFTR-delF508 Really Absent from the Apical Membrane of the Airway Epithelium?

Borthwick, L.A.; Botha, P.; Verdon, B.; Brodlie, M.J.; Gardner, A.; Bourn, D.; Johnson, G.E.; Gray, M.A.; Fisher, A.J.

Is CFTR-delF508 Really Absent from the Apical Membrane of the Airway Epithelium? Thumbnail


Authors

L.A. Borthwick

P. Botha

B. Verdon

M.J. Brodlie

A. Gardner

D. Bourn

G.E. Johnson

M.A. Gray

A.J. Fisher



Abstract

Background Understanding where mutant CFTR is localised in airway epithelia is essential in guiding the best therapeutic approach to correct the dysfunction of the CFTR protein. The widely held paradigm is that CF patients harbouring the commonest mutation, CFTR-delF508, trap CFTR within the endoplasmic reticulum and target it for degradation. However there are conflicting reports concerning expression and localisation of CFTR-delF508 in lung tissue. To attempt to resolve this fundamental issue we developed a novel approach to measure CFTR-delF508 in the lower airways of patients who have undergone lung transplantation for advanced CF. By sampling CF and non-CF epithelium simultaneously from the same individual, confounding factors of different airway microenvironments which may have influenced previous observations can be overcome. Methods Epithelia sampled by bronchial brushing above (CF) and below (non-CF) the bronchial anastomosis were stained for CFTR and the localisation and level of expression assessed (n = 12). Results There was no significant difference in the proportion of tall columnar cells showing CFTR immunostaining as a discrete band at the apical membrane in cells harbouring the CFTR-delF508 mutation compared to non-CF cells (p = 0.21, n = 12). However, the amount of CFTR expressed at the apical surface was reduced by ~50% in CF cells compared to non-CF cells (p = 0.04, n = 5). Conclusions Our novel observation challenges the prevailing paradigm that CFTR is essentially absent from the apical membrane of respiratory cells harbouring the CFTR-delF508 mutation. Moreover, it raises the possibility that the new generation of CFTR potentiators may offer a realistic therapeutic option for CF patients.

Citation

Borthwick, L., Botha, P., Verdon, B., Brodlie, M., Gardner, A., Bourn, D., …Fisher, A. (2011). Is CFTR-delF508 Really Absent from the Apical Membrane of the Airway Epithelium?. PLoS ONE, 6(8), https://doi.org/10.1371/journal.pone.0023226

Journal Article Type Article
Publication Date Jan 1, 2011
Deposit Date Nov 23, 2011
Publicly Available Date Jan 24, 2012
Journal PLoS ONE
Publisher Public Library of Science
Peer Reviewed Peer Reviewed
Volume 6
Issue 8
DOI https://doi.org/10.1371/journal.pone.0023226
Public URL https://durham-repository.worktribe.com/output/1503199

Files

Published Journal Article (464 Kb)
PDF

Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/

Copyright Statement
Copyright: © 2011 Borthwick et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.





You might also like



Downloadable Citations